We found significantly higher numbers of infiltrating CD4+ T cells in the brains of mice treated with the combination of anti-4-1BB and anti-CTLA-4 antibodies as well as the mice treated with triple therapy when compared to brains of non-tumor bearing mice (Fig. 4A; p<0.05). The gene discussed is TNFRSF9; the disease is neoplasm.